27.81USD-4.12%Mkt Cap: 1.57B USDP/E: —Last update: 2026-05-26
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap1.57B USD
Enterprise Value1.48B USD
Revenue (TTM)322.02M USD
Gross Profit196.23M USD
Net Income (TTM)-95.57M USD
Revenue/Share5.756 USD
Last Price27.81 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees888
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-33.41
PEG—
EV/EBITDA-14.45
EV/Revenue4.59
P/S5.11
P/B4.73
EPS (TTM)-1.83
EPS (Forward)-0.87
52W Range
19.3518% of range66.85
52W High66.85 USD
52W Low19.35 USD
Profitability
Gross Margin63.70%
Oper. Margin-39.22%
EBITDA Margin-31.79%
Profit Margin-31.02%
ROE-26.12%
ROA-18.81%
Growth
Revenue Growth20.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-48.98M USD
CapEx (TTM)9.36M USD
FCF Margin-13.41%
FCF Yield-2.75%
Net Debt-167.64M USD
Net Debt/EBITDA1.64
Balance Sheet
Debt/Equity0.21
Current Ratio6.73
Quick Ratio5.38
Book Value/Sh6.110 USD
Cash/Share4.316 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)30.44 USD
Target Range20.00 USD – 37.00 USD
# Analysts9
Ownership
Shares Out.56.92M
Float55.59M
Insiders3.13%
Institutions102.72%
Short Interest
Short Ratio4.4d
Short % Float10.86%
Short % Out.10.55%
Shares Short6.00M
Short (prev mo.)5.87M
Technical
SMA 5025.30 (+9.9%)
SMA 20031.33 (-11.3%)
Beta0.83
S&P 52W Chg28.31%
Avg Vol (30d)1.48M
Avg Vol (10d)1.88M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—